Navigation Links
China Agri-Business Announces 2008 Operating Results

NEW YORK, April 3 /PRNewswire-Asia-FirstCall/ -- China Agri-Business, Inc. (OTC Bulletin Board: CHBU) a manufacturer of biochemical agricultural application products through its operating company in China, announced its financial results for the year ended December 31,2008.

Revenue for the year ended December 31, 2008 totaled $2,922,385, a decrease of 3.8% as compared to $3,037,414 for the year ended December 31, 2007. The Company's operations were adversely affected by natural and weather related disasters that occurred in China in 2008, specifically severe winter weather conditions in January and February, a major earth quake on May 12 epicentered in Sichuan province, and widespread flooding in the central and southern regions in May and June, including the Hunan and Hubei provinces. Sales in each of these areas declined significantly.

Gross Profit for the year ended December 31, 2008 was $2,104,913, an increase of 1.6% as compared to $2,072,453 for the year ended December 31, 2007. Gross profit margin rate for the year ended December 31, 2008 was 72.03%, as compared to 68.23% for the year ended December 31, 2007. The improvement in gross margin is primarily attributable to a 5-10% increase in the prices of the Company's products.

The Company reported net income of $1,345,339, or $0.10 per share for 2008, as compared to $1,058,882, or $0.09 per share, respectively, for 2007. These increases are primarily attributed to the higher gross profit margin rate, lower professional fees, and lower general and administrative expenses in 2008 relative to 2007.

Liping Deng, President and CEO of China Agri-Business, stated, "We are pleased that we were able to maintain our sales despite weather and natural disasters beyond our control. Despite these setbacks, we remain focused on growth through new product development and expansion of our sales and marketing efforts in China."

Mr. Deng went on to say, "During 2008 we launched a new sales and marketing initiative called the "New Agriculture-Generator" designed to expand our distribution network in China. One component of this initiative involves establishing relationships with farmers through agricultural cooperatives. Another component is the "Super Chain Sales Partner" campaign, whereby the Company agrees to provide a $3,000 advance payment to participating retailers in exchange for their commitment to purchase and sell approximately $14,000 worth of the Company's products per year on an exclusive basis. We believe this program provides an opportunity to establish a direct connection with our primary consumers, the farmers, that will supplement our traditional sales network."

                            China Agri-Business, Inc.
                               Financial Highlights

                                               December 31,       December 31,
                                                     2008               2007
    Current Assets
     Cash and cash equivalents                  $8,312,636         $5,984,448
     Accounts receivable, net                       45,165             65,118
     Inventory                                      47,113             60,582
     Other current assets                           29,674             12,590
    Total Current Assets                         8,434,588          6,122,738
    Property, plant and equipment, net             231,278            276,000
    Investment in Tienwe Technology                879,420            822,540
    Deferred financing costs, net                  178,879                 --
    Intangible assets, net                          59,495             73,554
    Total Assets                                $9,783,660         $7,294,832

    Current Liabilities
     Accounts payable and accrued liabilities     $234,007           $166,200
    Long Term Liabilities
     Convertible notes, net                        327,020                 --
    Stockholders' Equity
     Common stock par value $.001 per
      share; authorized 100,000,000
      shares; issued and outstanding
      12,958,574 and 12,958,574 shares,
      respectively                                  12,959             12,959
     Additional paid-in capital                  4,369,786          4,150,636
     Retained earnings                           3,654,212          2,308,873
     Accumulated other comprehensive income      1,185,676            656,164
    Total stockholders' equity                   9,222,633          7,128,632
    Total Liabilities and Stockholders'
     Equity                                     $9,783,660         $7,294,832

    Results of Operations                                  Years Ended
                                                           December, 31
                                                      2008               2007
    Sales of products                           $2,922,385         $3,037,414
    Cost of goods sold                             817,472            964,961
    Gross profit                                 2,104,913          2,072,453
    Selling, general and administrative
     expenses                                      729,278          1,029,230
    Income from operations                       1,375,635          1,043,223
    Interest (expense) income                      (30,296)            15,659
    Net income                                  $1,345,339         $1,058,882*
    Earnings per common share:
     Basic                                           $0.10              $0.09*

    * Not included deemed dividend relating to beneficial conversion feature
      of Series A preferred stock


China Agri-Business, Inc., through its operating company in China, Shaanxi Xin Sheng Centennial Agriculture and Technology Co., Ltd. manufactures and sells non-toxic fertilizer, bactericide and fungicide products used for farming in China. Crops grown with Xinsheng's products are eligible to qualify for the "AA Green Food" rating administered by the China Green Food Development Center, an agency under the jurisdiction of the Ministry of Agriculture of the People's Republic of China (However, our products themselves do not bear the "AA green food" designation). The green food rating system, which consist of an "A" rating and a more stringent "AA" rating. The "AA" rating indicates that the crops contain minimal chemical residue from fertilizers.

The Company's two primary product groups are organic fungicides(Xinsheng Luyuan brand) and bactericides (Xinsheng Lufeng brand). The Company has a total of five brands and produces more than 50 different proprietary applications, including products designed to stimulate plant growth, condition soil, and prevent and cure plant diseases and parasites. The Company has products for a variety of crops, including potatoes, vegetables, cotton and fruit plants, and orchard trees. The products can be used either alone or to supplement other products. The Company Xinsheng's manufacturing facilities are located in Xian, Shaanxi Province, China.

Cautionary Note Regarding Forward-Looking Statements

This document contains forward-looking information about the Company's operating results and business prospects that involve substantial risks and uncertainties. Statements that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, but are not limited to, statements about the Company's plans, objectives, expectations, strategies, intentions or other characterizations of future events or circumstances and are generally identified by the words "may," "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "could," "would," and similar expressions. Because these forward-looking statements are subject to a number of risks and uncertainties, the Company's actual results could differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading "Risk Factors" in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2008, filed with the United States Securities and Exchange Commission and available at The Company assumes no obligation to update any such forward-looking statements.

SOURCE China Agri-Business, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Biologic Products Announces Strong 2008 Results
2. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
3. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
4. China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
5. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
6. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
7. China-Biotics, Inc. Appoints New Chief Financial Officer
8. China Medical Technologies Senior Management Purchased Company Shares
9. China Bio-Immunity Corporation - Rabies Vaccine Recall
10. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
11. China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):